No Data
No Data
No Data
No Data
No Data
Cybin Inc. CEO to Speak at Milken Global Conference
TipRanksApr 25 08:08 ET
Cybin to Participate at the 27th Annual Milken Institute Global Conference
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced that Doug Drysdale, Cybin's Chief Executive Officer, will be speaking at the 27th Annual Milken Institute Global Conference on a panel entitled "Collaborating for Improved Mental Health."
BusinesswireApr 25 07:30 ET
Cybin Inc. Unveils Promising Psychedelic Research
TipRanksApr 18 08:17 ET
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
- Publication explores structure-activity relationships ("SAR") of a broad range of 2C-X analogs - - Innovative research led to the discovery of CYB210010, a potent and long-acting serotonin 5-HT2 receptor agonist
BusinesswireApr 18 07:30 ET
Cedar Clinical Research Selected as Clinical Research Site for Cybin's Phase 3 Study of CYB003
VANCOUVER, BC, April 17, 2024 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behaviora
PR NewswireApr 17 07:00 ET
Cybin Inc. Secures Patent, Progresses MDD Therapy
TipRanksApr 16 08:09 ET
Simon 5183 : 等第三期人体试验成功,药品经过FDA核准上市后,这支股票将会冲天,如是上市失败,那持股人就
No Data
No Data
JESSE JAMES8832 : ive been waiting for it to get back down there.. ive never seen a stock get as much good news as this and just not really move
Simon 5183 : 因为是新的东西大家并不重视,好消息是全美国第一家迷幻蘑菇诊所今年已经在俄勒冈州开诊,治疗一次2000美金,预约排队人数已经累积2000多人